Bioprocessing and biomanufacturing
Discover advances in bioprocessing and biomanufacturing, from cell line development and upstream processing to downstream purification, scale-up, process optimisation and digital technologies that improve efficiency, product quality and commercial production outcomes.
Webinars and whitepapers
- Previous
- Next
Bioprocessing and biomanufacturing
Why authenticity is key for biopharma leaders
Drawing on more than 20 years in the industry and a few unexpected lessons, CPHI Awards 2026 – Woman of the Year finalist, FUJIFILM Biotechnologies’ President and Chief Operating Officer Maja Pedersen, reflects on how leading as your authentic self produces better outcomes for teams, organisations and patients.
Strategies for scaling complex next-generation biologics
As biologic drug formats grow more sophisticated, scalable success depends on embedding manufacturability, analytics and quality thinking into molecular design from the very beginning of development.
Large-scale AAV manufacturing for non-rare diseases
As AAV therapies move beyond rare disease indications, manufacturing scalability becomes critical. Learn how an integrated approach to process development can help reduce risk, improve yields, and prepare for commercial success.
Pharma Horizons: Formulation
Discover the key technologies, risk mitigation strategies and development considerations shaping modern pharmaceutical formulation — from early-stage selection through to commercial-scale manufacturing.
Join now
Unlock exclusive industry insights
- Bookmark articles and resources to access anytime
- Enjoy free access to industry leading resources, webinars and insights
- Stay informed with the latest news and breakthroughs in drug discovery
- Receive updates and recommendations tailored to your research interests
Building the pharmaceutical facility that is ready for change
As pharmaceutical manufacturing becomes more complex and responsive, Andy Lynam, Country Sales Manager at Rockwell Automation, explains why the Facility of the Future depends on connecting production, quality and data around a flexible digital operating model.
European Pharmaceutical Review Issue 2 2026
EPR Issue 2 includes articles on manufacturing, drug formulation, microbiology, downstream bioprocessing, and more.
The next era of pharmaceutical innovation: from emerging technologies to scalable solutions
Explore seven expert perspectives on the technologies and challenges shaping the future of pharmaceutical development and manufacturing.
Testo at CPHI 2026 in Milan: digital monitoring for the pharmaceutical industry
At CPHI 2026, Testo will showcase digital solutions for monitoring, compliance, and supply chain transparency in the pharmaceutical industry.
What will shape the future of advanced therapies in Europe?
Following his opening keynote at this year’s Advanced Therapies Europe conference in Barcelona, Professor Jacob George, MHRA Chief Medical & Scientific Officer, explores the evolving regulatory landscape for advanced therapy medicinal products.
How can we ensure consistency in decentralised cell therapy manufacturing?
Following her presentation at Advanced Therapies Europe, Charlotte Serra navigates the complexities of decentralised cell therapy manufacturing.
Precision control for target protein degraders
Target protein degraders offer therapeutic potential, yet their high potency, poor solubility and ultra-low administered doses place significant demands on formulation science, analytical capability, containment and scalable manufacture. Successful development requires solubility enhancement, particle engineering, excipient design, high-potency containment and process development to be considered together from the earliest programme stages.
Nitrosamines: from detection to understanding
Manufacturers are facing a new generation of nitrosamine challenges as NDSRIs demand more sophisticated analytical and risk management strategies.
Redefining the standard for recessed lighting in the pharmaceutical industry
Pharmaceutical and chemical manufacturing facilities present some of the most demanding lighting challenges in industry, combining explosive atmospheres, stringent hygiene requirements and complex regulatory requirements. Raytec examines how explosion-protected LED solutions are redefining safety, performance and compliance across hazardous area applications.
Closing the data integrity gap in pharmaceutical quality control
Pharmaceutical quality control laboratories face growing pressure to strengthen data integrity as regulators scrutinise incomplete records, manual data entry, and disconnected systems.
Transforming mycoplasma testing for faster biotherapeutic quality control
As biotherapeutic manufacturing accelerates, rapid PCR-based methods are enabling manufacturers to detect mycoplasma contamination sooner. However, realising their full potential requires robust validation, risk-based implementation and integration with a wider contamination-control strategy.
CHO perfusion model lifts yield by letting cellular waste build up
A hybrid model built into commercial software and running a self-driving bioreactor has found that unmeasured cellular waste, not the usual metabolites, throttles perfusion yields.
Troubleshooting capping defects in brittle tablet formulations
Cam-driven technology optimises the compaction process by maintaining consistent tablet hardness across turret speeds, enabling robust, scalable manufacturing of capping-prone blends.
What Annex 22 spells for AI in GMP manufacturing
Europe’s first dedicated framework for artificial intelligence in GMP manufacturing is close to finalisation and it is more demanding and more consequential than many manufacturers may currently appreciate.
Staying competitive within the evolving CDMO model
CEO of Lupin Manufacturing Solutions, shares his perspective on what differentiates credible CDMO entrants as pharmaceutical pipelines shift towards structurally complex molecules.
Day three preview: the Future of Bio/Pharma Analysis Virtual Summit 2026
Pharmaceutical manufacturing takes centre stage on Day three of The Future of Bio/Pharmaceutical Analysis Virtual Summit 2026 as speakers examine how digital technologies, artificial intelligence and advanced production methods are reshaping what is possible in the field.
Implementing horizontal recycling for pharmaceutical release liners
Closed-loop backing paper recycling enables manufacturers to convert release liner waste into circular materials without modifications to existing printers or labellers, meanwhile ensuring EU packaging waste regulation compliance.
Breaking the biomanufacturing mould: a patient-centric CDMO approach
Helen Bickley, Chief Quality Officer, FUJIFILM Biotechnologies reveals a new agile approach to biologics production that adopts a modular strategy for greater flexibility and ease.
Real-time Raman spectroscopy closes bioprocess control measurement gap
Manual sampling cycles leave bioreactor control decisions hours behind culture dynamics. Process Raman spectroscopy offers continuous, real-time measurement of critical parameters, enabling true closed-loop control in perfusion and continuous bioprocessing applications where measurement lag directly impacts yield and product quality.
Process Raman spectroscopy: closing biomanufacturing’s measurement infrastructure gap
The biopharmaceutical industry has embraced Pharma 4.0 concepts, but the measurement infrastructure required to realise autonomous facilities and continuous bioprocessing remains underdeveloped. Process Raman spectroscopy offers continuous, non-destructive monitoring at frequencies aligned with cell culture dynamics, bridging the gap between control system capabilities and available data.
European Pharmaceutical Review Issue 1 (2026): Environmental Monitoring In-Depth Focus
This In-Depth Focus explores how BPCs, RMMs and AI-enabled analytics are being evaluated as a tool to enhance aseptic manufacturing, bioburden testing and monitoring.
European Pharmaceutical Review Issue 1 2026
EPR Issue 1 includes articles on manufacturing, drug delivery, environmental monitoring, analytical techniques and more.
Optimising the downstream process in lentiviral vector manufacturing
Sartorius BIA Separations illustrates a promising alternative approach for efficient lentiviral vector purification that delivers a scalable, GMP-ready biomanufacturing solution.
Pharma Horizons: Trends in Pharmaceutical Manufacturing
EPR’s 2026 pharma manufacturing trends report covers the key developments in supply chain, quality, drug development, new modalities and beyond.